Imexpharm

Imexpharm FCF per Share

The Free Cash Flow per Share of Imexpharm (IMP.VN) as of Oct 26, 2026 is 177.21 VND. In the previous year, Free Cash Flow per Share was 775.91 VND — a change of -77.16% (lower).

FCF per Share

177.21VND

YoY

-77.16%

Last updated:

Free Cash Flow per Share of Imexpharm is 2025 177.21 VND. Free Cash Flow per Share of Imexpharm was 2024 775.91 VND. It decreases by -77.16% lower compared to the previous year.

The Imexpharm FCF per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF per Share
Date
FCF per Share
Jan 1, 2018
-2,185.33 VND
Jan 1, 2019
-989.93 VND
Jan 1, 2020
-247.95 VND
Jan 1, 2021
2,730.16 VND
Jan 1, 2022
4,188.45 VND
Jan 1, 2023
-1,479.41 VND
Jan 1, 2024
775.91 VND
Jan 1, 2025
177.21 VND
The Imexpharm FCF per Share history
YEARFCF per ShareYoY
177.21VND-77.16%
775.91VND-152.45%
-1,479.41VND-135.32%
4,188.45VND+53.41%
2,730.16VND-1,201.09%
-247.95VND-74.95%
-989.93VND-54.70%
-2,185.33VND-23.35%
-2,851.04VND+626.96%
-392.18VND-35.99%
-612.72VND+28.68%
-476.14VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Free Cash Flow per Share of Imexpharm is 177.21 VND in 2025.

Free Cash Flow per Share of Imexpharm changed from 775.91 VND to 177.21 VND, representing a -77.16% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow per Share Imexpharm since 2006 – with annual values, charts, and detailed analysis.

FCF per share measures the free cash flow allocated to each outstanding share. It is a key metric for assessing shareholder value creation.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Imexpharm

All Key Metrics — Imexpharm